Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment

被引：0
|
作者：
N. Saleh
P. Petursson
B. Lagerqvist
H. Skúladóttir
A. Svensson
B. Eliasson
S. Gudbjörnsdottir
K. Eeg-Olofsson
A. Norhammar
机构：
[1] Karolinska University Hospital,Cardiology Unit, Department of Medicine
[2] Sahlgrenska University Hospital,Department of Cardiology
[3] Uppsala University,Department of Medical Sciences
[4] Centre of Registers in Region Västra Götaland,Department of Medicine, Sahlgrenska University Hospital
[5] University of Gothenburg,undefined
来源：
Diabetologia | 2012年 / 55卷
关键词：
Coronary angiography; Coronary artery disease; Diabetes; Insulin; Mortality; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：2109 / 2117
页数：8
相关论文
共 50 条
  • [41] Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
    Huang, Qi
    Zou, Xiantong
    Chen, Yingli
    Gao, Leili
    Cai, Xiaoling
    Zhou, Lingli
    Gao, Fei
    Zhou, Jian
    Jia, Weiping
    Ji, Linong
    ISCIENCE, 2023, 26 (11)
  • [42] Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
    Bongaerts, Brenda
    Arnold, Suzanne, V
    Charbonnel, Bernard H.
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Rathmann, Wolfgang
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [43] Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics
    Hafiz Muhammad Adnan Tariq
    Nayyab Younas Khan
    Haseeb Manzoor
    Masood Ur Rehman Kayani
    Discover Medicine, 2 (1):
  • [44] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
    Kabadi, Udaya M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 140 - 140
  • [45] Trial Compares Glucose-Lowering Drugs for Type 2 Diabetes
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (16): : 1581 - 1581
  • [46] Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes
    Kim, Young-Il
    Kim, Young Ae
    Kim, Hak Jin
    Kim, Su-Hyun
    Hwangbo, Yul
    Kim, Jae Gyu
    Kim, Jae J.
    Choi, Il Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (03): : 584 - +
  • [47] Intensification of polypharmacy glucose-lowering treatment in type-2 diabetes: When to be cautious?
    Charbonnel, Bernard
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (01) : 3 - 5
  • [48] Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
    Marjolein M. J. Zanders
    Harm R. Haak
    Myrthe P. P. van Herk-Sukel
    Lonneke V. van de Poll-Franse
    Jeffrey A. Johnson
    Diabetologia, 2015, 58 : 951 - 960
  • [49] Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
    Zanders, Marjolein M. J.
    Haak, Harm R.
    van Herk-Sukel, Myrthe P. P.
    van de Poll-Franse, Lonneke V.
    Johnson, Jeffrey A.
    DIABETOLOGIA, 2015, 58 (05) : 951 - 960
  • [50] Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus
    Masako Saito
    Atsunori Kaibara
    Takeshi Kadokura
    Junko Toyoshima
    Satoshi Yoshida
    Kenichi Kazuta
    Eiji Ueyama
    Diabetes Therapy, 2020, 11 : 951 - 964
12345